The Price of Abandoning Diagnostic Testing for Cell Free Fetal Dna Screening

Prenatal Diagnosis - United States
doi 10.1002/pd.5226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Comment on the Commentary by Evans Et Al Entitled ‘The Price of Abandoning Diagnostic Testing for Cell Free DNA Screening'.

Prenatal Diagnosis
GynecologyGeneticsObstetrics
2018English

Using Cell-Free Fetal DNA as a Diagnostic and Screening Test: Current Understanding and Uncertainties

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2016English

Antenatal Screening for Fetal Trisomies Using Microarray‐based Cell‐free DNA Testing – A Systematic Review and Meta‐analysis

Prenatal Diagnosis
GynecologyGeneticsObstetrics
2020English

Diagnostic and Prognostic Role of Cell-Free DNA Testing for Colorectal Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
2017English

Implementation of Maternal Blood Cell-Free DNA Testing in Early Screening for Aneuploidies

Medizinische Genetik
Genetics
2019English

Cell-Free Fetal DNA and Spontaneous Preterm Birth

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2018English

Noninvasive Prenatal Testing From Cell-Free DNA

CMAJ
Medicine
2014English

Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis

British Journal of General Practice
MedicineFamily Practice
2009English

The Use of Low Molecular Weight Heparin Reduced the Fetal Fraction and Rendered the Cell-Free DNA Testing for Trisomy 21 False Negative

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy